Table 1.
Demographic characteristics of adult cancer survivors reporting one of the five mutually exclusive types of USC in 2013–2018 Medical Expenditure Panel Survey (MEPS) data
| Variables | Weighted total (n = 31,953,477) | Unweighted number of observations (%) (n = 2690) |
p-value | ||||
|---|---|---|---|---|---|---|---|
| Non-hospital facility (n = 540) | Hospital-based facility (n = 433) | Solo practicing physician (n = 656) | A specific person in a non-hospital facility (n = 751) | A specific person in a hospital-based facility (n = 310) | |||
| % (SE) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
|
| |||||||
| Race | < 0.001 | ||||||
| Non-Hispanic White | 81.4 (1.1) | 372 (68.89) | 232 (53.58) | 444 (67.68) | 583 (77.63) | 207 (66.77) | |
| Non-Hispanic Black | 7.7 (0.7) | 71 (13.15) | 74 (17.09) | 84 (12.80) | 95 (12.65) | 48 (15.48) | |
| Other | 11.0 (0.8) | 35 (6.48) | 24 (5.54) | 42 (6.40) | 25 (3.33) | 16 (5.16) | |
| Sex | 0.130 | ||||||
| Female | 54.2 (1.4) | 308 (57.04) | 223 (51.50) | 353 (53.81) | 424 (56.46) | 154 (49.68) | |
| Male | 45.8 (1.4) | 232 (42.96) | 210 (48.50) | 303 (46.19) | 327 (43.54) | 156 (50.32) | |
| Region | < 0.001 | ||||||
| Northeast | 20.9 (1.5) | 98 (18.15) | 53 (12.24) | 171 (26.07) | 180 (23.97) | 37 (11.94) | |
| Midwest | 22.8 (1.6) | 104 (19.26) | 102 (23.56) | 92 (14.02) | 170 (22.64) | 92 (29.68) | |
| South | 34.8 (1.6) | 218 (40.37) | 132 (30.48) | 273 (41.62) | 276 (36.75) | 88 (28.39) | |
| West | 21.5 (1.3) | 120 (22.22) | 146 (33.72) | 120 (18.29) | 125 (16.64) | 93 (30.00) | |
| Age categories | < 0.001 | ||||||
| 18–49 years | 10.6 (0.8) | 85 (15.74) | 91 (21.01) | 61 (9.30) | 73 (9.72) | < 30 (< 9.68) | |
| 50–64 years | 27.9 (1.3) | 156 (28.89) | 128 (29.56) | 190 (28.96) | 179 (23.83) | > 79 (> 25.48) | |
| 65–74 years | 31.5 (1.2) | 166 (30.74) | 120 (27.71) | 203 (30.95) | 261 (34.75) | 109 (35.16) | |
| ≥ 75 years | 30.0 (1.4) | 133 (24.63) | 94 (21.71) | 202 (30.79) | 238 (31.69) | 92 (29.68) | |
| Calendar year | < 0.001 | ||||||
| 2013 | 12.2 (0.9) | 78 (14.44) | 48 (11.09) | 85 (12.96) | 79 (10.52) | < 30 (< 9.68) | |
| 2014 | 16.4 (1.0) | 84 (15.56) | 58 (13.39) | 81 (12.35) | 110 (14.65) | 36 (11.61) | |
| 2015 | 10.6 (0.7) | 67 (12.41) | 51 (11.78) | 76 (11.59) | 61 (8.12) | < 30 (< 9.68) | |
| 2016 | 21.0 (1.0) | 119 (22.04) | 114 (26.33) | 147 (22.41) | 129 (17.18) | 50 (16.13) | |
| 2017 | 20.7 (0.9) | 143 (26.48) | 109 (25.17) | 123 (18.75) | 142 (18.91) | 61 (19.68) | |
| 2018 | 19.1 (1.0) | 49 (9.07) | 53 (12.24) | 144 (21.95) | 230 (30.63) | 120 (38.71) | |
| Education | < 0.001 | ||||||
| High school diploma or higher | 89.6 (0.7) | 464 (85.93) | 336 (77.60) | 554 (84.45) | 657 (87.48) | 271 (87.42) | |
| Less than high school diploma/Unknown | 10.4 (0.7) | 76 (14.07) | 97 (22.40) | 102 (15.55) | 94 (12.52) | 39 (12.58) | |
| Family income | < 0.001 | ||||||
| High (≥ 200% of FPL) | 74.8 (1.2) | 362 (67.04) | 256 (59.12) | 461 (70.27) | 546 (72.70) | 201 (64.84) | |
| Low (< 200% of FPL) | 25.2 (1.2) | 178 (32.96) | 177 (40.88) | 195 (29.73) | 205 (27.30) | 109 (35.16) | |
| Insurance (throughout the year) | 0.028 | ||||||
| Any private/uninsured | 67.3 (1.5) | 319 (59.07) | 243 (56.12) | 413 (62.96) | 474 (63.12) | 172 (55.48) | |
| Public only | 32.7 (1.5) | 221 (40.93) | 190 (43.88) | 243 (37.04) | 277 (36.88) | 138 (44.52) | |
| Comorbidities | 0.384 | ||||||
| 0 | 14.2 (0.9) | 79 (14.63) | 81 (18.71) | 107 (16.31) | 114 (15.18) | 42 (13.55) | |
| 1 | 24.9 (1.2) | 128 (23.70) | 111 (25.64) | 163 (24.85) | 167 (22.24) | 77 (24.84) | |
| ≥ 2 | 60.9 (1.4) | 333 (61.67) | 241 (55.66) | 386 (58.84) | 470 (62.58) | 191 (61.61) | |
| Being in remission | 0.664 | ||||||
| No | 73.4 (1.2) | 399 (73.89) | 320 (73.90) | 485 (73.93) | 539 (71.77) | 236 (76.13) | |
| Yes | 26.6 (1.2) | 141 (26.11) | 113 (26.10) | 171 (26.07) | 212 (28.23) | 74 (23.87) | |
| Health status round 3/1 | 0.028 | ||||||
| Excellent | 13.4 (0.9) | 57 (10.56) | 40 (9.24) | 78 (11.89) | 110 (14.65) | 37 (11.94) | |
| Very good | 28.4 (1.1) | 143 (26.48) | 98 (22.63) | 170 (25.91) | 199 (26.50) | 79 (25.48) | |
| Good | 31.5 (1.1) | 172 (31.85) | 137 (31.64) | 216 (32.93) | 252 (33.56) | 102 (32.90) | |
| Fair | 18.5 (1.0) | 105 (19.44) | 114 (26.33) | 125 (19.05) | 135 (17.98) | > 62 (> 20.00) | |
| Poor | 8.2 (0.7) | 63 (11.67) | 44 (10.16) | 67 (10.21) | 55 (7.32) | < 30 (9.68) | |
| Cancer site | |||||||
| Breast | 21.7 (1.1) | 105 (19.44) | 94 (21.71) | 129 (19.66) | 168 (22.37) | 78 (25.16) | 0.243 |
| Prostate | 17.4 (1.0) | 85 (15.74) | 86 (19.86) | 120 (18.29) | 139 (18.51) | 63 (20.32) | 0.415 |
| Melanoma# | 12.7 (0.9) | 57 (10.56) | 36 (8.31) | 69 (10.52) | 84 (11.19) | 38 (12.26) | 0.467 |
| Any other cancer except breast cancer, prostate cancer, and melanoma | 49.8 (1.4) | 300 (55.56) | 221 (51.04) | 345 (52.59) | 365 (48.60) | 137 (44.19) | 0.029 |
USC, usual source of care; FPL, Federal poverty line; SE, standard error
#
Not mutually exclusive of breast cancer and prostate cancer
Note: Weighted total percentage and standard error values are for the US civilian non-institutionalized population of adult cancer survivors currently experiencing cancer and having a usual source of care during 2013–2018. Percentages may not add up to 100.0% due to rounding. p-values based on chi-square tests. Cell sizes < 30 have been collapsed